Pathogen-reduced platelets for the prevention of bleeding.
BACKGROUND: Platelet transfusions are used to prevent and treat bleeding in patients who are thrombocytopenic. Despite improvements in donor screening and laboratory testing, a small risk of viral, bacterial or protozoal contamination of platelets remains. There is also an ongoing risk from newly e...
Main Authors: | Butler, C, Doree, C, Estcourt, L, Trivella, M, Hopewell, S, Brunskill, S, Stanworth, S, Murphy, M |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2013
|
Registos relacionados
-
Pathogen-reduced platelets for the prevention of bleeding (Review)
Por: Butler, C, et al.
Publicado em: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (protocol)
Por: Butler, C, et al.
Publicado em: (2011) -
Pathogen-reduced platelets for the prevention of bleeding (Review)
Por: Estcourt, L, et al.
Publicado em: (2017) -
Pathogen-reduced platelets for the prevention of bleeding in people of any age
Por: Estcourt, L, et al.
Publicado em: (2018) -
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
Por: Estcourt, L, et al.
Publicado em: (2015)